We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleCMG launches UC-II, a collagen-based supplement for joint mobility Product targets knee pain and st...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleKids’ vitamins boomed after Covid Aussie supplement brands win big in China’s wellness craze EZZ su...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticleBanks lead ASX200 comeback Tech sinks after Wisetech crashes on boardroom drama Reece, Iress slum...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleASX health and wellness stocks among companies which attended the 7th China International Import Ex...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleStocks declined on Thursday as rising tensions in the Middle East left investors uneasy ahead of Sep...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleUS stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to ne...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleUS stocks jumped overnight, with the Dow Jones Industrial Average and the S&P 500 rising to new...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleContinued interest in AI and the big tech stocks provided the momentum to push the three main inde...
Read ArticleContinued interest in AI and the big tech stocks provided the momentum to push the three main indexe...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleMomentum investing has been shown to be a successful strategy over the long term. The strategy essen...
Read ArticleA momentum trader will essentially be “buying high, but hoping to sell even higher” – which is the c...
Read ArticleMomentum-oriented investors live by the saying “the trend is your friend”. In essence, a momentum tr...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleA growing middle class and younger generation concerned about their health and wellness driving sec...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleStocks settled lower on Thursday as investors remain cautious ahead of key jobs data on Friday tha...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleMorgans says companies on the ASX are propelling our appetite product for health and wellness produ...
Read ArticleStocks fell Thursday as Treasury yields popped to multiyear highs and investors grew worried that...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleASX up +0.35% on Chinese inflation data China’s CPI moved higher in August, easing concerns of defl...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleShareCafeMarkets rally on cooler inflation data Stocks jumped Thursday as t...
Read ArticleShareCafeUS stocks rise after banks look to bail out First Republic Stocks...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleShareCafeUS investors wait for Friday’s jobs report: Cannabis stocks the highlight ...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleThe ASX had a positive start to the week, driven by financial and travel stocks, despite global mark...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleSummary Audalia Resources reported cash and cash equivalents of AU$162,000 in the quarter ended...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleMedtech company Oneview Health (ASX:ONE) led 25 stocks that chalked up a 14-day RSI above 70 this we...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSummary With COVID-19 giving the opportunity to develop products, enhance services and conduct R...
Read ArticleSummary Austin Engineering has bagged contracts worth over $35 million. It is witnessing softnes...
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, August 21. Data is taken after the marke...
Read ArticleThe Vita Life Sciences Limited (ASX: VLS) share price has today rocketed higher following impressiv...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleIn the Australian health care system, three levels of government are responsible for providing unive...
Read ArticleFor a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Ove...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleNote: This is a re-publication, with permission, of a newspaper column that was originally published...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
